She has managed operations and development programmes from research to development transition through scale-up and process technology transfer. Previously as a consultant, she has developed and implemented operational effectiveness programmes across the whole R&D spectrum, from organizational start-ups to programme optimizations and improvements in the UK, Europe and the US.
Tina is a pharmaceutical sciences PhD formerly with SmithKlineBeecham Pharmaceuticals. After a switch to pharmaceuticals consulting with Coopers & Lybrand and then PriceWaterhouse Coopers, Tina began working as an independent consultant in pharmaceuticals, largely in the biotechnology sector. Recent assignments have included leadership of process improvement programmes in Research and Development, project management of IT infrastructure upgrade, and technical expert input to start-up and venture-capital stage biotech projects. Tina has worked with Prosensa Therapeutics since 2009, where she is VP of Alliances and Project Management, overseeing the R&D pipeline and operations.